YASMIN

This brand name is authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Finland, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug YASMIN contains a combination of these active pharmaceutical ingredients (APIs):

1	Drospirenone UNII N295J34A25 - DROSPIRENONE
	Drospirenone is a progestogen. In a therapeutic dosage, drospirenone also possesses antiandrogenic and mild antimineralocorticoid properties. It has no estrogenic, glucocorticoid and antiglucocorticoid activity. This gives drospirenone a pharmacological profile closely resembling the natural hormone progesterone.
	Read more about Drospirenone
2	17 alpha-Ethinylestradiol UNII 423D2T571U - ETHINYL ESTRADIOL
	Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy.
	Read more about 17 alpha-Ethinylestradiol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
YASMIN Film-coated tablet	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AA12	Drospirenone and ethinylestradiol	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AA Progestogens and estrogens, fixed combinations
Discover more medicines within G03AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	538912050015713, 538912070018003, 538913050022403, 538915060023503
CA	Health Products and Food Branch	02261723, 02261731
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.893-11-07
ES	Centro de información online de medicamentos de la AEMPS	00-2881, 2000-02881IP, 23022-17-4-2008, 3303827505, 63575, 63576, 8069-1-2-11, PL00010-0571, RVG23827
FI	Lääkealan turvallisuus- ja kehittämiskeskus	002391, 003911, 004000
GB	Medicines & Healthcare Products Regulatory Agency	139812, 26464, 378893
HK	Department of Health Drug Office	48905
HR	Agencija za lijekove i medicinske proizvode	HR-H-993460030
IE	Health Products Regulatory Authority	53010
IL	מִשְׂרַד הַבְּרִיאוּת	4400, 4401
LT	Valstybinė vaistų kontrolės tarnyba	1091723
MT	Medicines Authority	MA639/02801, PI1438/05301A, PI908/16401B
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	322M2002
NL	Z-Index G-Standaard, PRK	56774
NZ	Medicines and Medical Devices Safety Authority	9899
PL	Rejestru Produktów Leczniczych	100031517, 100129788, 100258209, 100264760, 100266083, 100267770, 100268159, 100305222, 100324662, 100336270, 100346310, 100349745, 100351370, 100405751, 100417435, 100426730, 100446603, 100458883, 100460054
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W63899001, W63899002, W63899003, W63899004
SG	Health Sciences Authority	12334P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546093953, 8699546093960
ZA	Health Products Regulatory Authority	34/18.8/0494